Imperva (IMPV) Tops Q2 EPS by 7c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
Go back to Imperva (IMPV) Tops Q2 EPS by 7c
July 27, 2018 8:56 AM EDT
Susquehanna lowered its price target on Imperva (NASDAQ: IMPV) to $59.00 (from $60.00) while maintaining a Positive rating.
Analyst Anne Meisner commented, "Imperva's stronger-than-expected mix-shift to subscription revenue drives lower guidance near term but should result in accelerating recurring revenue."
...
More
July 27, 2018 6:39 AM EDT
DA Davidson downgraded Imperva (NASDAQ: IMPV) from Buy to Neutral with a price target of $46.00 (from $56.00).
For an analyst ratings summary and ratings history on Imperva click here. For more ratings news on Imperva click here.
Shares of Imperva closed at $56.70 yesterday.
...
More
July 27, 2018 6:08 AM EDT
Oppenheimer downgraded Imperva (NASDAQ: IMPV) from Outperform to Perform.
Analyst Shaul Eyal offers three reasons for the downgrade:
We clearly understand IMPV's model transition towards a subscription-driven one and are encouraged by FlexProtect's (hybrid product) strong traction, but we are slightly...
More
July 27, 2018 5:51 AM EDT
Deutsche Bank lowered its price target on Imperva (NASDAQ: IMPV) to $47.00 (from $50.00) while maintaining a Hold rating.
...
More
July 26, 2018 4:46 PM EDT
Imperva, Inc. (NASDAQ: IMPV) today announced it signed an agreement to acquire Prevoty. Together, Imperva and Prevoty will provide comprehensive security solutions to protect application services residing on-premises and in the cloud. This solution aligns with how organizations are developing and deploying... More
